9ALPHA,15S-DIHYDROXY-11-OXO-PROSTA-5Z,13E,17Z-TRIEN-1-OIC ACID
- $65 - $296
- Product name: 9ALPHA,15S-DIHYDROXY-11-OXO-PROSTA-5Z,13E,17Z-TRIEN-1-OIC ACID
- CAS: 71902-47-1
- MF: C20H30O5
- MW: 350.45
- EINECS:
- MDL Number:MFCD00216049
- Synonyms:9ALPHA,15S-DIHYDROXY-11-OXO-PROSTA-5Z,13E,17Z-TRIEN-1-OIC ACID;PROSTAGLANDIN D3;(Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S,5Z)-3-hydroxyocta-1,5-dienyl]-3-oxocyclopentyl]hept-5-enoic acid;(5Z,13E,15S,17Z)-9α,15-Dihydroxy-11-oxoprosta-5,13,17-trien-1-oic acid;PGD3;Prostaglandin D3;Prostaglandin D3 Exclusive;ANOICLBSJIMQTA-WXGBOJPQSA-N
4 prices
Selected condition:
Brand
- AHH
- Cayman Chemical
Package
- 25μg
- 50μg
- 100μg
- 0.5g
- ManufacturerAHH
- Product numberMT-09900
- Product description9alpha,15S-Dihydroxy-11-oxo-prosta-5Z,13E,17Z-trien-1-oicacid 98%
- Packaging0.5g
- Price$296
- Updated2021-12-16
- Buy
- ManufacturerCayman Chemical
- Product number12990
- Product descriptionProstaglandin D3 ≥98%
- Packaging25μg
- Price$65
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number12990
- Product descriptionProstaglandin D3 ≥98%
- Packaging50μg
- Price$98
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number12990
- Product descriptionProstaglandin D3 ≥98%
- Packaging100μg
- Price$169
- Updated2024-03-01
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AHH | MT-09900 | 9alpha,15S-Dihydroxy-11-oxo-prosta-5Z,13E,17Z-trien-1-oicacid 98% | 0.5g | $296 | 2021-12-16 | Buy |
Cayman Chemical | 12990 | Prostaglandin D3 ≥98% | 25μg | $65 | 2024-03-01 | Buy |
Cayman Chemical | 12990 | Prostaglandin D3 ≥98% | 50μg | $98 | 2024-03-01 | Buy |
Cayman Chemical | 12990 | Prostaglandin D3 ≥98% | 100μg | $169 | 2024-03-01 | Buy |
Properties
Boiling point :561.2±50.0 °C(Predicted)
Density :1.166±0.06 g/cm3(Predicted)
storage temp. :Store at -20°C
solubility :DMF: >100 mg/ml (from PGD2); DMSO: >50 mg/ml (from PGD2); Ethanol: >75 mg/ml (from PGD2); PBS pH 7.2: >5 mg/ml (from PGD2)
pka :4.76±0.10(Predicted)
Density :1.166±0.06 g/cm3(Predicted)
storage temp. :Store at -20°C
solubility :DMF: >100 mg/ml (from PGD2); DMSO: >50 mg/ml (from PGD2); Ethanol: >75 mg/ml (from PGD2); PBS pH 7.2: >5 mg/ml (from PGD2)
pka :4.76±0.10(Predicted)
Safety Information
Symbol(GHS): | |||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Danger | ||||||||||||||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||||||||||||||
Precautionary statements: |
|
Description
Prostaglandin D3 (PGD3) is produced by the metabolism of EPA via the COX pathway. It is equipotent to PGD2 in decreasing systemic blood pressure in rats and in decreasing intraocular pressure in rabbits. However, it is 3-5 times more potent than PGD2 in the inhibition of ADP-induced human platelet aggregation.More related product prices